Inflammatory markers response to citrulline supplementation in patients with non-alcoholic fatty liver disease: a randomized, double blind, placebo-controlled, clinical trial

@lipo_fan @MohammedAlo @agingdoc1 @JeffA47854828 @neeche41 @Clint_OMeley @drpablocorral @nicknorwitz @realDaveFeldman @DudzLightLime @DietHeartNews Any merit looking at L- Citrulline as an ADJUNCT for ASCVD? ⬇️BP, CRP/TNF-alpha/IL6, HbA1C ⬆️NO,RCT/Eflux

RT @PeterJAnderson_: @guuseh @performance392 @MohammedAlo (hs-CRP) , (NF-κB) ,(TNF-α) was reduced in Cit group significantly more than pla…

@guuseh @performance392 @MohammedAlo (hs-CRP) , (NF-κB) ,(TNF-α) was reduced in Cit group significantly more than placebo https://t.co/gvERw2AAUV

@drjkahn https://t.co/gvERw2AAUV